AlphAIAlphAI — Financial news for AI agents
247wallst.comOCT 92 min read$PLTR

Goldman Sachs Upgrades Palantir to Buy, Sees 18% Upside and Further Outperformance Into 2027

Goldman Sachs upgraded Palantir (PLTR) to Buy with a $230 price target, citing an 18% upside and potential outperformance into 2027. The analyst highlights sovereign AI, bespoke applications, and verticalization as growth drivers. Palantir reported Q2 2026 revenue of $1.94B, up 92.83% YoY, and raised full-year guidance. The stock is up 11.29% YTD.

Original reporting
247wallst.com
Published Oct 9, 2026, 5:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 5:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Goldman Sachs Upgrades Palantir to Buy, Sees 18% Upside and Further Outperformance Into 2027 — source image
Source · 247wallst.com
Decision brief

The 30-second read

$PLTRBullishHigh
01

Why it matters

The upgrade and higher guidance could attract new institutional buying and lift the stock's momentum.

02

Market read

Analyst upgrade with a $230 target and raised FY revenue outlook is a fresh catalyst for PLTR, likely prompting short‑term buying.

03

What to watch

Potential slowdown in sovereign AI spending and execution risk on the aggressive revenue guidance.

Relevance 7/10Novelty 7/10Timing: today

Background

Goldman Sachs analyst Gabriela Borges highlighted sovereign AI, bespoke applications, and verticalization as growth drivers for Palantir.

Company-level read

Ticker impact

$PLTRBullishHigh confidence
Context

Goldman Sachs upgraded Palantir to Buy, set a $230 price target and raised full-year revenue guidance.

Expected impact

upward pressure as traders price in the higher target and guidance

Evidence & confidence

Analyst upgrade with a concrete price target and improved guidance typically triggers a short‑term rally.

Market effects

Sector

Boosts sentiment for AI and data‑analytics software sector.

Regional

Primarily U.S. market impact; may influence tech‑heavy indices.

Global

Limited to investors tracking high‑growth AI plays.

Counterpoint

What could challenge this read

The upgrade may be premature given Palantir's high valuation and reliance on government contracts.

Key entities

  • Analyst
    Goldman Sachs

    Issuer of the upgrade and price target.

  • Company
    Palantir

    Subject of the upgrade and guidance raise.

Read at source← All news

StoryGoldman Sachs upgrades Palantir to Buy on sovereign AI growth

Also covered by

6 outlets

Related articles

OCT 9
$PLTRMed

Goldman Predicts a “Step Function Change” in Palantir’s AI Opportunity

Goldman Sachs upgraded Palantir (PLTR) to Buy with a $230 price target, citing growth in sovereign AI, bespoke software, and industry-specific sales. Analyst Gabriela Borges expects revenue to nearly quadruple by fiscal 2028. The stock trades at 102.4x forward earnings, near its five-year average. Goldman notes Palantir's operating margin improved from -26.7% in 2021 to 31.6% in 2025.

finance.yahoo.com2 min
OCT 9
$PLTRMed

How Much Growth Are You Paying For In Palantir Stock?

Palantir (PLTR) stock rose 57% in three months, outpacing the S&P 500. Goldman Sachs upgraded it to buy. Trading at 158.1x P/E, investors expect significant profit growth. Revenue grew 93% YoY in Q2 2026, driven by U.S. commercial sales. Management aims to sustain this growth. Q3 2026 revenue guidance is $2.16B-$2.164B. International growth is weaker, and the stock is volatile during market downturns.

finance.yahoo.com2 min
OCT 9
$PLTRHigh

Palantir Stocks Rise 2.4% as Goldman Backs Sovereign AI

Palantir Technologies (PLTR) shares rose 2.4% to $203.57 after Goldman Sachs upgraded its rating to Buy with a $230 price target. The upgrade was driven by sovereign AI demand, with U.S. government revenue up 90% to $809 million in Q2. The company also raised its full-year U.S. commercial revenue outlook above $3.424 billion. However, shares are 10% above the GF Value estimate, leaving less room for execution errors.

gurufocus.com2 min
OCT 9
$PLTRMed

Palantir Rises 4% as Barclays Starts Coverage at Overweight With $265 Target; ServiceNow Holds Steady, Salesforce Sits Tight

Palantir (PLTR) rose 4% to $205.77 after Barclays initiated coverage with an Overweight rating and $265 target. Goldman Sachs also upgraded PLTR to Buy with a $230 target. ServiceNow (NOW) and Salesforce (CRM) lagged. Barclays' note cited demand for sovereign AI systems. PLTR's growth differs from peers due to large government and enterprise contracts.

247wallst.com2 min
OCT 9
$SPCXMed

Barclays Makes Major Call on SpaceX, Palantir Stocks

Barclays initiated coverage of SpaceX (SPCX) and Palantir (PLTR) with Overweight ratings, citing strong competitive advantages, growth, and profitability. Analyst Anthony Valentini set price targets of $254 for SpaceX and $265 for Palantir. Both stocks rose in premarket trading, with SpaceX up 3.7% and Palantir up 1%.

finance.yahoo.com2 min